ADAM metallopeptidase with thrombospondin type 1 motif, 7
RGD ID:
1306713
Description:
Predicted to enable metalloendopeptidase activity. Predicted to be involved in several processes, including cellular response to cytokine stimulus; collagen fibril organization; and skeletal system development. Predicted to be located in cell surface. Predicted to be active in extracellular matrix. Orthologous to human ADAMTS7 (ADAM metallopeptidase with thrombospondin type 1 motif 7); INTERACTS WITH (+)-schisandrin B; 1-naphthyl isothiocyanate; 17alpha-ethynylestradiol.
A disintegrin and metalloproteinase with thrombospondin motifs 7; a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 7; ADAM-TS 7; ADAM-TS7; ADAMTS-7; ADAMTS7B; COMPase; LOC315879
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ADAMTS7 protein
[Cisplatin co-treated with jinfukang] results in increased expression of ADAMTS7 mRNA and [Cisplatin co-treated with Paclitaxel] results in decreased expression of ADAMTS7 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ADAMTS7 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ADAMTS7 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ADAMTS7 protein
